Taylor & Francis | Choose Open Access | Oncology

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

You could be eligible to publish Open Access with a much-reduced Article Publishing Charge (APC) or in many cases at no cost at all.

Did you know that most Taylor & Francis oncology journals give you the option to publish your research open access? Choosing this option allows your work to be more accessible and ensures you reach the widest possible audience. We have partnered with institutions and funders in Sweden and around the world to help researchers publish open access in their chosen journals. 

Find out more about whether you are eligible and how to take advantage of this partnership:

Find out more

Molecular & Cellular Oncology

2020 CiteScore 2.0
162K Annual Downloads

Molecular & Cellular Oncology publishes original papers, reviews, perspectives and commentaries on oncogenesis, tumor progression and therapeutics for solid and hematological cancers.

Visit Journal Submit

Acta Oncologica

2020 Impact Factor 4.089
Five-Year Impact Factor 4.236

Acta Oncologica publishes research into oncology, covering the etiology and treatment for all cancer types as well as experimental and clinical cancer research.

Visit Journal Submit


 

Cancer Biology & Therapy

2020 Impact Factor 4.742
Five-Year Impact Factor 4.342

This journal publishes articles on the molecular basis of cancer, including translational diagnostic relevance or therapy, reviews, op-ed pieces and meeting reports..

Visit Journal Submit

Nutrition and Cancer

2020 Impact Factor 2.900
Five-Year Impact Factor 3.144

Nutrition and Cancer reports research on the impact of nutrition on cancer etiology, therapy, and prevention, covering topics like, carcinogenesis, dietetics, and food policies.

Visit Journal Submit


 

Pediatric Hematology and Oncology

2020 Impact Factor 1.969
Five-Year Impact Factor 2.026

This journal publishes pediatric research in blood disorders and malignancies, including pharmacology, stem cells, molecular targeting, immune therapies & transplantation.

Visit Journal Submit

More Journals

Discover the complete Oncology portfolio and find the perfect home for your research.
Read more

Your open access choices with Taylor & Francis

Open access is great for readers because it gives them immediate access to the latest research. But what are the advantages of publishing open access to you, the author?
Find out why you should publish open access

SHARE THIS PAGE

Latest tweets from @tandfmedicine